MDDI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

9 Medical Technologies Poised to Explode in 2016: Liquid Biopsy

Liquid Biopsy Liquid biopsy, a less-invasive alternative to conventional biopsy, analyzes blood for circulating tumor cells to detect cancer. Liquid biopsy, which

Liquid Biopsy
Liquid biopsy, a less-invasive alternative to conventional biopsy, analyzes blood for circulating tumor cells to detect cancer.

Liquid biopsy, which eschews conventional, invasive tissue biopsies in favor of a blood test that’s analyzed for the presence of circulating tumor cells, is one technology Divyaa Ravishankar, transformational health senior industry analyst at Frost & Sullivan, predicts will hit its stride in 2016.

“Promising applications for the use of this next-generation sequencing are prostate cancer, breast cancer, colorectal cancer, and lung cancer,” she says, adding that Sequenom, Trovagene, and RainDance Technologies are leaders in the space. 

          
Learn more about emerging medical technologies at the MD&M West conference and expo February 9-11, 2016, in Anaheim, CA.

 

[image courtesy of PRAISAENG/FREEDIGITALPHOTOS.NET]

 

Filed Under
500 characters remaining